Latest Insider Transactions at Kala Pharmaceuticals, Inc. (KALA)
This section provides a real-time view of insider transactions for Kala Pharmaceuticals, Inc. (KALA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Kala Pharmaceuticals, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Kala Pharmaceuticals, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 26
2024
|
Romulus K Brazzell |
SELL
Open market or private sale
|
Direct |
5,489
-6.13%
|
$21,956
$4.75 P/Share
|
|
Jun 26
2024
|
Mark T Iwicki CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
15,168
-5.44%
|
$60,672
$4.75 P/Share
|
|
Jun 26
2024
|
Mary Reumuth CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
4,163
-6.47%
|
$16,652
$4.75 P/Share
|
|
Jun 26
2024
|
Darius Kharabi CHIEF BUSINESS OFFICER |
SELL
Open market or private sale
|
Direct |
5,158
-7.95%
|
$20,632
$4.75 P/Share
|
|
Jun 26
2024
|
Todd Bazemore |
SELL
Open market or private sale
|
Direct |
4,653
-5.31%
|
$18,612
$4.75 P/Share
|
|
Jun 11
2024
|
Mark S. Blumenkranz |
BUY
Grant, award, or other acquisition
|
Direct |
1,400
+9.66%
|
-
|
|
Jun 11
2024
|
Andrew I Koven |
BUY
Grant, award, or other acquisition
|
Direct |
1,750
+11.17%
|
-
|
|
Jun 11
2024
|
C. Daniel Myers |
BUY
Grant, award, or other acquisition
|
Direct |
1,400
+15.02%
|
-
|
|
Jun 11
2024
|
Gregory D Perry |
BUY
Grant, award, or other acquisition
|
Direct |
1,400
+11.39%
|
-
|
|
Jun 11
2024
|
Marjan Farid |
BUY
Grant, award, or other acquisition
|
Direct |
1,400
+15.23%
|
-
|
|
Jun 11
2024
|
Howard B Rosen |
BUY
Grant, award, or other acquisition
|
Direct |
1,400
+9.16%
|
-
|
|
May 31
2024
|
Mark T Iwicki CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
7,392
-2.58%
|
$44,352
$6.09 P/Share
|
|
May 31
2024
|
Romulus K Brazzell |
SELL
Open market or private sale
|
Direct |
2,002
-2.19%
|
$12,012
$6.09 P/Share
|
|
May 31
2024
|
Mary Reumuth CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,786
-2.7%
|
$10,716
$6.09 P/Share
|
|
May 31
2024
|
Darius Kharabi CHIEF BUSINESS OFFICER |
SELL
Open market or private sale
|
Direct |
231
-0.35%
|
$1,386
$6.09 P/Share
|
|
May 31
2024
|
Todd Bazemore |
SELL
Open market or private sale
|
Direct |
2,093
-2.33%
|
$12,558
$6.09 P/Share
|
|
Jan 04
2024
|
Romulus K Brazzell |
SELL
Open market or private sale
|
Direct |
1,617
-1.74%
|
$9,702
$6.74 P/Share
|
|
Jan 04
2024
|
Romulus K Brazzell |
BUY
Grant, award, or other acquisition
|
Direct |
6,500
+6.53%
|
-
|
|
Jan 04
2024
|
Darius Kharabi CHIEF BUSINESS OFFICER |
SELL
Open market or private sale
|
Direct |
1,385
-2.08%
|
$8,310
$6.73 P/Share
|
|
Jan 04
2024
|
Darius Kharabi CHIEF BUSINESS OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
4,600
+6.47%
|
-
|
|
Jan 04
2024
|
Eric Trachtenberg |
SELL
Open market or private sale
|
Direct |
1,227
-1.77%
|
$7,362
$6.74 P/Share
|
|
Jan 04
2024
|
Eric Trachtenberg |
BUY
Grant, award, or other acquisition
|
Direct |
4,600
+6.23%
|
-
|
|
Jan 04
2024
|
Todd Bazemore |
SELL
Open market or private sale
|
Direct |
1,405
-1.54%
|
$8,430
$6.74 P/Share
|
|
Jan 04
2024
|
Todd Bazemore |
BUY
Grant, award, or other acquisition
|
Direct |
6,500
+6.65%
|
-
|
|
Jan 04
2024
|
Mary Reumuth CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,227
-1.82%
|
$7,362
$6.74 P/Share
|
|
Jan 04
2024
|
Mary Reumuth CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
4,600
+6.39%
|
-
|
|
Jan 04
2024
|
Mark T Iwicki CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
4,539
-1.56%
|
$27,234
$6.73 P/Share
|
|
Jan 04
2024
|
Mark T Iwicki CHIEF EXECUTIVE OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
14,300
+4.69%
|
-
|
|
Jun 22
2023
|
Mark T Iwicki CHIEF EXECUTIVE OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
158,873
+36.49%
|
-
|
|
Jun 22
2023
|
Mark S. Blumenkranz |
BUY
Grant, award, or other acquisition
|
Direct |
4,884
+17.46%
|
-
|
|
Jun 22
2023
|
Todd Bazemore |
BUY
Grant, award, or other acquisition
|
Direct |
48,698
+36.51%
|
-
|
|
Jun 22
2023
|
Romulus K Brazzell |
BUY
Grant, award, or other acquisition
|
Direct |
49,356
+36.52%
|
-
|
|
Jun 22
2023
|
Mary Reumuth CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
36,144
+36.54%
|
-
|
|
Jun 22
2023
|
Eric Trachtenberg |
BUY
Grant, award, or other acquisition
|
Direct |
37,559
+36.73%
|
-
|
|
Jun 22
2023
|
Gregory D Perry |
BUY
Grant, award, or other acquisition
|
Direct |
6,956
+25.74%
|
-
|
|
Jun 22
2023
|
Darius Kharabi CHIEF BUSINESS OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
36,847
+37.31%
|
-
|
|
Jun 22
2023
|
Howard B Rosen |
BUY
Grant, award, or other acquisition
|
Direct |
9,088
+24.66%
|
-
|
|
Jun 22
2023
|
Andrew I Koven |
BUY
Grant, award, or other acquisition
|
Direct |
8,915
+25.71%
|
-
|
|
Jun 22
2023
|
C. Daniel Myers |
BUY
Grant, award, or other acquisition
|
Direct |
4,884
+27.76%
|
-
|
|
Jun 22
2023
|
Marjan Farid |
BUY
Grant, award, or other acquisition
|
Direct |
4,792
+27.89%
|
-
|
|
May 31
2023
|
Mark T Iwicki CHIEF EXECUTIVE OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
71,715
+37.87%
|
-
|
|
May 31
2023
|
Todd Bazemore |
BUY
Grant, award, or other acquisition
|
Direct |
21,158
+37.02%
|
-
|
|
May 31
2023
|
Romulus K Brazzell |
BUY
Grant, award, or other acquisition
|
Direct |
17,916
+32.95%
|
-
|
|
May 31
2023
|
Mark S. Blumenkranz |
BUY
Grant, award, or other acquisition
|
Direct |
1,640
+19.42%
|
-
|
|
May 31
2023
|
Andrew I Koven |
BUY
Grant, award, or other acquisition
|
Direct |
2,197
+40.28%
|
-
|
|
May 31
2023
|
Mary Reumuth CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
14,736
+35.63%
|
-
|
|
May 31
2023
|
C. Daniel Myers |
BUY
Grant, award, or other acquisition
|
Direct |
1,640
+50.0%
|
-
|
|
May 31
2023
|
Eric Trachtenberg |
BUY
Grant, award, or other acquisition
|
Direct |
15,639
+36.56%
|
-
|
|
May 31
2023
|
Gregory D Perry |
BUY
Grant, award, or other acquisition
|
Direct |
1,738
+40.65%
|
-
|
|
May 31
2023
|
Darius Kharabi CHIEF BUSINESS OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
2,648
+9.56%
|
-
|